Open Label Study for the Functional Characterization of Drug Metabolism and Transport
Phase 1
Completed
- Conditions
- Genotype-related Drug Metabolism
- Interventions
- First Posted Date
- 2013-02-11
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- Matthias Schwab
- Target Recruit Count
- 144
- Registration Number
- NCT01788254
- Locations
- 🇩🇪
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany
🇩🇪Abteilung Klinische Pharmakologie, Tübingen, Germany
Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine
Phase 1
Terminated
- Conditions
- Drug Metabolism, Poor, CYP2D6-RELATED
- Interventions
- First Posted Date
- 2011-02-04
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- Matthias Schwab
- Target Recruit Count
- 49
- Registration Number
- NCT01289938
- Locations
- 🇩🇪
Abteilung Klinische Pharmakologie, UKT Tübingen, Tübingen, BW, Germany
Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing
- First Posted Date
- 2007-10-01
- Last Posted Date
- 2014-02-25
- Lead Sponsor
- Matthias Schwab
- Target Recruit Count
- 68
- Registration Number
- NCT00537732
- Locations
- 🇩🇪
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Baden-Württemberg, Germany
© Copyright 2025. All Rights Reserved by MedPath